Tianeptine, initially created as a therapeutic drug in France , has ignited considerable discussion internationally. Unlike most antidepressants which act by increasing serotonin levels, tianeptine suggests to promote mood transport and affects glutamate , resulting in distinct responses. Its accessibility through unregulated channels , often bypas